Endeavour Vision and Abingworth Lead Funding Redwood City, CA – July 22, 2015 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has raised $43 million in an equity financing. The equity financing was co-led by new investor Endeavour Vision, a technology […]
More than 100 Competitors in Medtech’s Premier Design Competition Redwood City, CA (June 30, 2015)—Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that its Sonata System was selected as the Bronze Winner in the Radiological and Electromechanical Devices Category at the 18th Annual Medical […]
FAST-EU Trial 6 Month Results Published in Gynecological Surgery; 12 Month Results presented at 43rd Annual AAGL Meeting. REDWOOD CITY, CA – December 9, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the recent publication and presentation of results from the […]
Distinct Alternative to Surgery, Radiological Approaches and Power Morcellation, for the Treatment of Symptomatic Uterine Fibroids. REDWOOD CITY, CA – October 22, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has received approval from the U.S. Food and Drug Administration […]
Veteran Medical Device Executive with Expertise in Clinical, Reimbursement, Sales, Marketing REDWOOD CITY, CA – August 7, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has named veteran medical device executive Richard P. Lanigan as Vice President, Global Commercialization, effective […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the first treatment of a patient in Cologne, Germany, using the Company’s newly-designed VizAblate® System. VizAblate is the only medical device to integrate ultrasound imaging with radiofrequency ablation in a single handheld device […]
The Only System to Combine and Integrate Ultrasound Imaging with Radiofrequency Ablation in a Single Device June 12, 2014 10:00 AM Eastern Daylight Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, Inc., a women’s healthcare company that has developed a minimally invasive device for the treatment of symptomatic uterine fibroids, announced today that it has received CE Mark […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that it has named veteran medical device executive Christopher M. Owens as President and Chief Executive Officer, effective immediately. Owens has nearly 25 years of medical device experience and was most recently […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, Inc., a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced today a Series D financing led by HBM Partners based in Switzerland. The $21 million financing included additional new investor Correlation Ventures and existing investors Abingworth, Advanced Technology Ventures (ATV) and InterWest Partners. Gynesonics will use […]
- « Previous
- 1
- 2
- 3
